Company intelligence / Profile preview

Apertus Pharmaceuticals

Ballwin, Missouri, United Statesapertuspharma.com ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Apertus Pharmaceuticals is an FDA-inspected contract manufacturing company specializing in the development and manufacture of APIs and finished dose forms, including prescription and OTC products. In partnership with API Innovation Center and Glioblastoma Foundation, they manufacture lomustine for brain tumors to address US drug shortages, using continuous manufacturing technology.

Therapeutic areas: OncologyOther
Modalities: Small moleculeTabletCapsuleCreamSuppositoryLiquid
Industry: Contract Manufacturing Organization

Partnerships

API Innovation CenterGlioblastoma Foundation

Beyond the preview

Go deeper on Apertus Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apertus Pharmaceuticals.